top of page

Journal Articles


Disclaimer: The papers below are intended for private viewing by the page owner or those who otherwise have legitimate access to them. No part of it may in any form or by any electronic, mechanical, photocopying, recording, or any other means be reproduced, stored in a retrieval system or be broadcast or transmitted without the prior permission of the respective publishers. If your organization has a valid subscription of the journals, click on the DOI link for the legitimate copy of the papers.

View By Year Published


Morley-Forster PK, Pergolizzi JV, Taylor R Jr, Axford-Gatley RA, Sellers EM.

Mitigating the risk of opioid abuse through a balanced undergraduate pain medicine curriculum. J Pain Res. 2013 Dec 4; 6:791-801



Pergolizzi JV Jr, Taylor R Jr, Nalamachu S, Raffa RB, Carlson DR, Varanasi RK, Kopecky EA

Challenges of treating patients with chronic pain with dysphagia (CPD): physician and patient perspectives Curr Med Res Opin. 2013 Oct 28


Raffa RB, Taylor R Jr, Pergolizzi JV Jr

Sequestered naltrexone in sustained release morphine or oxycodone – a way to inhibit illicit use? Expert Opin Drug Saf. 2013 Nov 11


Raffa RB, Pergolizzi JV Jr.

Opioid-induced hyperalgesia: is it clinically relevant for the treatment of pain patients? Pain Manag Nurs. 2013 Sep; 14(3):e67-83


Pergolizzi JV Jr, Lequang JA

Abuse-Deterrent Formulations of Opioid Analgesics Pain Pract. 2013 Aug 6



Pergolizzi J, Ahlbeck K, Aldington D, Alon E, Coluzzi F, Dahan A, Huygen F, Kocot-Kępska M, Mangas AC, Mavrocordatos P, Morlion B, Müller-Schwefe G,Nicolaou A, Pérez Hernández C, Sichère P, Schäfer M, Varrassi G.

The development of chronic pain: physiological CHANGE necessitates a multidisciplinary approach to treatment Curr Med Res Opin 2013 Jul 3


Angeletti C, Guetti C, Ursini ML, Taylor R Jr, Papola R, Petrucci E, Ciccozzi A, Paladini A, Marinangeli F, Pergolizzi J, Varrassi G

Low Back Pain in a Natural Disaster Pain Pract. 2013 Jun 14



Summers K, Pergolizzi J, Ma L, Foster D, Overholser B, Sowinski K

The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs Value Health. 2013 May; 16(3):A12



Pergolizzi J, Hess G, Chang CL, Shah D, Pierz K, Benjoseph R

Factors predicting medication persistence among patients initiating Buprenorphine transdermal system Value Health. 2013 May; 16(3):A120



Pergolizzi J, Ben Joseph R, Chang CL, Pierz K, Shah D, Hess G

Impact of dosage strength on medication persistence among patients treated with buprenorphine transdermal system. Value Health. 2013 May; 16(3):A120



Pergolizzi JV.

Treatment of chronic pain in older people: evidence-based choice of strong-acting opioids. Drugs Aging. 2012 Dec; 29(12):993-5; author reply 997-8



Leslie JB, Raffa RB, Taylor R, Muniz E, Nalamachu S, Pergolizzi JV.

Essential Oxygen Oil for Treatment of Sport-Related Injuries American Journal of Sports Science and Medicine, 2013, Vol. 1, No. 1, 7-12


Merchante I, Pergolizzi J, van de Laar M, Mellinghoff HU, Nalamachu S, O’Brien J, Perrot S, and Raffa RB

Tramadol/Paracetamol Fixed-Dose Combination for Chronic Pain Management in Family Practice: A Clinical Review ISRN Family Medicine, vol. 2013, Article ID 638469, 15 pages, 2013



Apfel CC, Turan A, Souza K, Pergolizzi J, Hornuss C

Intravenous acetaminophen reduces postoperative nausea and vomiting: a systematic review and meta-analysis Pain. 2013 Jan 11. pii: S0304-3959(13)00009-2.



Obrien J, Pergolizzi J, van de Laar M, Mellinghoff HU, Moron Merchante I, Nalamachu S, Perrot S, Raffa RB

Fixed-dose combinations at the front line of multimodal pain management: perspective of the nurse-prescriber Nursing: Research and Reviews 2013:3


Pergolizzi JV, Raffa RB, Taylor R, Nagar S, Labhsetwar S, Sinclair N, Gould EM

An open-label pharmacokinetic study of oxymorphone extended release in the presence of naltrexone in the older adult J Opioid Manag. 2012 Nov-Dec; 8(6):383-93



van Laar M, Pergolizzi JV Jr, Mellinghoff HU, Merchante IM, Nalamachu S, O'Brien J, Perrot S, Raffa RB

Pain treatment in arthritis-related pain: beyond NSAIDs Open Rheumatol J. 2012; 6:320-30.



Taylor R, Pergolizzi JV, Raffa RB.

Tapentadol extended release for chronic pain patients. Adv Ther. 2013 Jan; 30(1):14-27



Pergolizzi JV Jr, Labhsetwar S, Lequang JA.

Compounding Pharmacies: Who is in Charge? Pain Pract. 2013 Jan 28



Pergolizzi, JV.

Treatment of Chronic Pain in Older People: Evidence-Based Choice of Strong-Acting Opioids Drugs Aging. 2012:12 (29): 993-95.


Pergolizzi J, Taylor R, Plancarte R, Muniz E.

Es la Buprenorfina una buena opción en el manejo de dolor postoperatorio? Rev Soc Esp Dolor 2012; 19(6): X-X


Yarlas A, Miller K, Wen W, Dain B, Lynch SY, Pergolizzi J, Raffa R, Ripa S.

A Randomized, Placebo-Controlled Study of the Impact of the 7-Day Buprenorphine Transdermal System on Health-Related Quality of Life in Opioid-Naïve Patients with Moderate-to-Severe Chronic Low Back Pain The Journal of Pain, Vol 13 No (1), 2013: pp 14-23


Raffa RB, Pergolizzi JV, Muniz E, Taylor R, and Pergolizzi J.

Designing Opioids That Deter Abuse Pain Research and Treatment 2012, Article ID 282981



Taylor R Jr, Pergolizzi JV, Sinclair A, Raffa RB, Aldington D, Plavin S, Apfel CC

Transversus Abdominis Block: Clinical Uses, Side Effects, and Future Perspectives Pain Pract. 2012 Sep 12.



Pergolizzi, Van de Laar M, Langford R, Mellinghoff HU, Merchante IM, Nalamachu S, O’Brien J, Perrot S, and Raffa RB.

Tramadol/paracetamol fixed-dose combination in the treatment of moderate to severe pain Journal of Pain Research 2012:5 327–346


Daitch J, Frey ME, Silver D, Mitnick C, Daitch D, Pergolizzi J.

Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine Pain Physician. 2012 Jul; 15(3 Suppl):ES59-66


Pergolizzi JV Jr, Philip BK, Leslie JB, Taylor R Jr, Raffa RB.

Perspectives on transdermal scopolamine for the treatment of postoperative nausea and vomiting J Clin Anesth. 2012 Jun; 24(4):334-45


Pergolizzi JV Jr, Gharibo C, Passik S, Labhsetwar S, Taylor R Jr, Pergolizzi JS, Müller-Schwefe G

Dynamic risk factors in the misuse of opioid analgesics J Psychosom Res. 2012 Jun; 72(6):443-51. Epub 2012 Apr 5


Pergolizzi JV Jr, Raffa RB, Taylor R Jr, Rodriguez G, Nalamachu S, Langley P.

A Review of Duloxetine 60 mg Once-Daily Dosing for the Management of Diabetic Peripheral Neuropathic Pain, Fibromyalgia, and Chronic Musculoskeletal Pain Due to Chronic Osteoarthritis Pain and Low Back Pain. Pain Pract. 2012 Jun 21



Pergolizzi JV, Raffa RB, Pergolizzi JS, Taylor R.

Non-Analgesic Effects of Opioids: Factors Relevant to Opioid Abuse and Abuse-Deterrent Formulations. Curr Pharm Des. 2012 Jun 28.


Angeletti C, Guetti C, Papola R, Petrucci E, Ursini ML, Ciccozzi A, Masi F, Russo MR, Squarcione S, Paladini A, Pergolizzi J, Taylor R Jr, Varrassi G, Marinangeli F.

Pain after earthquake Scand J Trauma Resusc Emerg Med. 2012 Jun 29; 20(1):43


Raffa RB, Pergolizzi JV Jr.

Is Morphine Medicine’s Biggest Misnomer? Ann Pharmacother. 2012 Jul 3


Taylor R Jr, Raffa RB, Pergolizzi JV Jr

Controlled release formulation of oxycodone in patients with moderate to severe chronic osteoarthritis: a critical review of the literature J Pain Res. 2012; 5:77-87. Epub 2012 Apr 23


Raffa RB, Burmeister JJ, Yuvasheva E, Pergolizzi JV Jr

QTc interval prolongation by d-propoxyphene: what about other analgesics? Expert Opin Pharmacother. 2012 May 9

Raffa RB, Tallarida RJ, Taylor R Jr, Pergolizzi JV Jr

Fixed-dose combinations for emerging treatment of pain Expert Opin Pharmacother. 2012 Mar 16


Pergolizzi J, Raffa R, Taylor R.

Low-dose transdermal buprenorphine system: an update Paineurope 2012: 1; 8-9


Raffa RB, Pergolizzi JV Jr.

Intracerebroventricular opioids for intractable pain Br J Clin Pharmacol. 2012 Feb 1



Taylor R, Lemtouni S, Weiss K, Pergolizzi J.

Pain Management in the Elderly: An FDA Safe Use Initiative Expert Panel’s View on Preventable Harm Associated with NSAID Therapy Current Gerontology and Geriatrics Research, vol. 2012, Article ID 196159, 9 pages, 2012



Raffa RB and Pergolizzi J.

Multi-mechanistic analgesia for opioid-induced hyperalgesia. Journal of Clinical Pharmacy and Therapeutics, 2012, 37, 125–127

bottom of page